Search research articles
Contact Us
Filters
Showing results (91-100 of 155) with videos related to
Page
of 16
Sort By:
The Journal of Applied Laboratory Medicine
|
October 23, 2019
Analytical Differences in Intraoperative Parathyroid Hormone Assays
Edward K Y Leung, Christine C Lee, Peter Angelos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 15, 2010
Temsirolimus has activity in non-mantle cell non-Hodgkin's lymphoma subtypes: The University of Chicago phase II consortium
Sonali M Smith, Koen van Besien, Theodore Karrison, et al.
Cancer Research
|
April 19, 2005
Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation
Erik T Kimchi, Mitchell C Posner, James O Park, et al.
Breast Cancer Research and Treatment
|
November 23, 2024
High tumor glucocorticoid receptor expression in early-stage, triple-negative breast cancer is associated with increased T-regulatory cell infiltration
Margarite D Matossian, Christine Shiang, Deniz Nesli Dolcen, et al.
Environment International
|
December 8, 2017
Pregnancy outcomes and ethanol cook stove intervention: A randomized-controlled trial in Ibadan, Nigeria
Donee A Alexander, Amanda Northcross, Theodore Karrison, et al.
Cancer
|
May 5, 2020
A randomized phase 2 study of temsirolimus and cetuximab versus temsirolimus alone in recurrent/metastatic, cetuximab-resistant head and neck cancer: The MAESTRO study
Tanguy Y Seiwert, Sara Kochanny, Kevin Wood, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 21, 2009
A phase I trial to determine the safety, tolerability, and maximum tolerated dose of deforolimus in patients with advanced malignancies
Christine M Hartford, Apurva A Desai, Linda Janisch, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 19, 2006
Outcome of treatment for congenital toxoplasmosis, 1981-2004: the National Collaborative Chicago-Based, Congenital Toxoplasmosis Study
Rima McLeod, Kenneth Boyer, Theodore Karrison, et al.
Breast Cancer Research and Treatment
|
February 10, 2025
A randomized phase II trial of nab-paclitaxel with or without mifepristone for advanced triple-negative breast cancer
Nan Chen, Margarite Matossian, Poornima Saha, et al.
Gynecologic Oncology
|
February 9, 2025
Metformin for patients with advanced stage ovarian cancer: A randomized phase II placebo-controlled trial
Iris L Romero, Ernst Lengyel, Andrea E Wahner Hendrickson, et al.
Page
of 16
Search research articles
Search
Showing results (91-100 of 155) with videos related to
Sort By:
Page
of 16
The Journal of Applied Laboratory Medicine
|
October 23, 2019
Analytical Differences in Intraoperative Parathyroid Hormone Assays
Edward K Y Leung, Christine C Lee, Peter Angelos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 15, 2010
Temsirolimus has activity in non-mantle cell non-Hodgkin's lymphoma subtypes: The University of Chicago phase II consortium
Sonali M Smith, Koen van Besien, Theodore Karrison, et al.
Cancer Research
|
April 19, 2005
Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation
Erik T Kimchi, Mitchell C Posner, James O Park, et al.
Breast Cancer Research and Treatment
|
November 23, 2024
High tumor glucocorticoid receptor expression in early-stage, triple-negative breast cancer is associated with increased T-regulatory cell infiltration
Margarite D Matossian, Christine Shiang, Deniz Nesli Dolcen, et al.
Environment International
|
December 8, 2017
Pregnancy outcomes and ethanol cook stove intervention: A randomized-controlled trial in Ibadan, Nigeria
Donee A Alexander, Amanda Northcross, Theodore Karrison, et al.
Cancer
|
May 5, 2020
A randomized phase 2 study of temsirolimus and cetuximab versus temsirolimus alone in recurrent/metastatic, cetuximab-resistant head and neck cancer: The MAESTRO study
Tanguy Y Seiwert, Sara Kochanny, Kevin Wood, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 21, 2009
A phase I trial to determine the safety, tolerability, and maximum tolerated dose of deforolimus in patients with advanced malignancies
Christine M Hartford, Apurva A Desai, Linda Janisch, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 19, 2006
Outcome of treatment for congenital toxoplasmosis, 1981-2004: the National Collaborative Chicago-Based, Congenital Toxoplasmosis Study
Rima McLeod, Kenneth Boyer, Theodore Karrison, et al.
Breast Cancer Research and Treatment
|
February 10, 2025
A randomized phase II trial of nab-paclitaxel with or without mifepristone for advanced triple-negative breast cancer
Nan Chen, Margarite Matossian, Poornima Saha, et al.
Gynecologic Oncology
|
February 9, 2025
Metformin for patients with advanced stage ovarian cancer: A randomized phase II placebo-controlled trial
Iris L Romero, Ernst Lengyel, Andrea E Wahner Hendrickson, et al.
Page
of 16